Clinical efficacy of treatment 60 cases of thoracic and lumbar spinal tuberculosis with Nano-hydroxyapatite/polyamide 66 composite bone filling material
XU Zu-yuan, ZHANG Qiang, FANG De-jian, ZHONG Xin
Department of Orthopedics, Guangzhou Chest Hospital and Tuberculosis Lab, State Key Laboratory of Respiratory Disease, Guangzhou 510095, China
[1]王传庆. 脊柱结核外科治疗的现状与进展. 结核病与肺部健康杂志,2013,2(1):64-68.[2]温从游,孟纯阳,蒋电明,等.纳米羟基磷灰石/聚酰胺66复合材料的研究及应用.中国组织工程研究,2014,18(3): 464-469.[3]Brantigan JW,Steffee AD.A carbon fiber implant to aid interbody lumbar fusion. Two-year clinical results in the first 26 patients.Spine(Phila Pa 1976),1993,18(14):2106-2117.[4]马远征. 重视脊柱结核 提高诊疗水平.中国防痨杂志,2013,35(5):297-298.[5]张嘉利,李大伟,马远征,等.多节段胸腰椎脊柱结核外科治疗的回顾性研究.中国防痨杂志,2013,35(5):305-308.[6]秦世炳. 重视结核病诊治和脊柱结核手术时机的选择. 中国骨伤,2013,26(7):533-535.[7]大会学术委员会. 骨关节结核诊疗共识(讨论稿). 结核病与肺部健康杂志,2012,1(3):206-212.[8]Wang H, Li Y, Zuo Y, et al. Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering.Biomaterials, 2007, 28(22):3338-3348.[9]Huang M, Feng J, Wang J, et a1.Synthesis and characterization of nano-HA/PA66 composites.J Mater Sci Mater Med,2003,14(7):655-660.[10]Ripamonti U, Crooks J, Khoali L, et al. The induction of bone formation by coral-derived calcium carbonate/hydroxya-patite constructs. Biomaterials, 2009,30(7):1428-1439.[11]Xu Q, Lu H, Zhang J, et a1. Tissue engineering scaffold material of porous nanohydroxyapatite/polyamide 66. Int J Nanomedicine, 2010,5:331-335.[12]Yang X, Song Y,Liu L,et a1.Anterior reconstruction with nano-hydroxyapatite/polyamide-66 cage after thoracic and lumbar corpectomy. Orthopedics,2012,35(1):e66-73.[13]宋跃明,陈日高,刘立岷,等.多孔纳米羟基磷灰石-聚酰胺66椎间融合器治疗胸腰椎爆裂骨折的早期临床研究,中华骨科杂志,2010,30(4):336-340.[14]杨曦,宋跃明,刘立岷, 等.应用纳米羟基磷灰石/聚酰胺66椎体支撑体重建脊柱前柱的中期效果.中华外科杂志,2014,52(1):20-24.[15]张宏其,郭超峰,唐明星,等. 一期后路病灶清除、异形钛网椎间植骨融合治疗胸、腰椎结核,中华骨科杂志,2014,34(2): 102-108.[16]金锋,白雪鹏,曹远国,等. 脊柱结核手术并发症的原因及预防.结核病与肺部健康杂志,2012,1(3):185-188.